HealthQuill Medical
At least 78% of the world’s nurses are concentrated in countries representing 49% of the population, according to a global nursing report published by the World Health Organization and the International Council of Nurses.
Health Medical Pharma

Global health goals face risks due to inequities in nursing profession: WHO

HQ Team May 12, 2025: At least 78% of the world’s nurses are concentrated in countries representing 49% of the population, according to.

Read More
Billionaire Bill Gates will donate more than $200 billion over the next two decades to prevent newborn child and maternal deaths, combat infectious diseases, Alzheimer’s, and close down the Gates Foundation on December 31, 2045.
Drugs Health Medical

Gates Foundation to shut in 2045, pledges $200 billion in next 20 years

HQ Team May 8, 2025: Billionaire Bill Gates will donate more than $200 billion over the next two decades to prevent newborn child.

Read More
Israel’s Teva Pharmaceutical Industries, and US-based Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.
Drugs Health Medical

Addressing India’s asthma crisis: Ensuring access to treatments for all

HQ Team May 7, 2025: It was World Asthma Day on May 6, and let us see how India has fared in the.

Read More
Social determinants such as quality housing, education, and job opportunities can influence people’s health outcomes more than genetic influences or access to healthcare, according to a WHO report.
Climate Health Medical

Housing, education, jobs vital to health outcomes, not genes: WHO

HQ Team May 6, 2025: Social determinants such as quality housing, education, and job opportunities can influence people’s health outcomes more than genetic.

Read More
In countries with low or middle incomes, physically punishing children result in poor health, lower academic performance and impaired social-emotional development, a study finds.
Health Medical Research

Physical punishment of kids leads to poor health: NYU researchers find

HQ Team May 6, 2025: In countries with low or middle incomes, physically punishing children result in poor health, lower academic performance and.

Read More
Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new under-the-skin injection version of the cancer therapy, nivolumab (Opdivo), offering a quicker administration option for eligible patients than the currently available drip treatment. 
Drugs Medical Pharma

UK regulator clears subcutaneous injection of Bristol Myers for cancers

HQ Team May 1, 2025: Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new under-the-skin injection version of the cancer.

Read More
A ten-fold increase in measles cases was reported from Europe last year, while the numbers shot up 11-fold this year until April 18, in the American region, according to two global health agencies.
Drugs Health Medical

In Europe measles up 10-fold last year, Americas region up by 11-fold in 2025

HQ Team April 29, 2025: A ten-fold increase in measles cases was reported from Europe last year, while the numbers shot up 11-fold.

Read More
Germany’s Merck KGaA, is set to acquire biopharmaceutical company SpringWorks Therapeutics Inc. for $3.9 billion in cash to add rare tumour therapies to its portfolio.
Drugs Medical Pharma

Merck to buy SpringWorks for $3.9b to add rare tumour medicines

HQ Team April 29, 2025: Germany’s Merck KGaA, is set to acquire biopharmaceutical company SpringWorks Therapeutics Inc. for $3.9 billion in cash to.

Read More
Italfarmaco SpA., a privately held Italian pharmaceutical and chemical company, received a recommendation for the conditional marketing in the European Union of an oral drug for Duchenne muscular dystrophy in patients six years or older, who can walk.
Drugs Medical Pharma

Italfarmaco gets conditional marketing nod in EU for DMD drug

HQ Team April 27, 2025: Italfarmaco SpA., a privately held Italian pharmaceutical and chemical company, received a recommendation for the conditional marketing in.

Read More
The European Medicines Agency has granted a marketing authorisation in the EU for Amgen Inc.’s medicine for treating thyroid eye disease, according to a statement.
Drugs Medical Pharma

Amgen’s thyroid eye disease medicine gets EU market authorisation

HQ Team April 27, 2025: The European Medicines Agency has granted a marketing authorisation in the EU for Amgen Inc.’s medicine for treating.

Read More